GlassScriptPhysician profile
Timothy Rearick
NPI 1386903821
$2,757.19
in general payments reported to CMS, 2019-2025
13 companies · $48.37 in 2025
The $48.37 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2021: $63.95 · 2022: $1,403 · 2023: $246 · 2024: $516 · 2025: $48.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Micromed INC | $1,200.00 | 2022 | |
| Wright Medical Technology, INC. | $375.41 | 2019 | |
| Arthrex, INC. | $360.43 | 2024 | |
| Bioventus LLC | $183.17 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Xcell |
| Treace Medical Concepts, INC. | $148.48 | 2022-2023 | |
| Saxum Surgical, INC. | $145.04 | 2023 | |
| Stryker Corporation | $110.11 | 2021-2025 | Gamma, Pangea |
| Paragon 28, INC. | $109.02 | 2019-2023 | Jaws |
| Boston Scientific Corporation | $36.39 | 2024 | Compliance Endokit |
| Pacira Therapeutics, INC. | $33.45 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $23.31 | 2024 | Iovera, Zilretta, Exparel |
| Depuy Synthes Sales INC. | $20.39 | 2022 | |
| Horizon Therapeutics Plc | $11.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Rearick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.